title: Two injections of interferon-alpha could trigger the development of rheumatoid arthritis.
authors.forename: M
authors.initials: M
authors.lastname: Funauchi
authors.forename: M
authors.initials: M
authors.lastname: Ohno
authors.forename: Y
authors.initials: Y
authors.lastname: Nozaki
authors.forename: K
authors.initials: K
authors.lastname: Kinoshita
authors.forename: M
authors.initials: M
authors.lastname: Sugiyama
authors.forename: A
authors.initials: A
authors.lastname: Kanamaru
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000473:pathology; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000601:surgery; D003545:Cysteine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D016898:Interferon-alpha; D003545:Cysteine; C026535:bucillamine